4.0
23 May 2026
Current employee, more than 10 years
Cambridge, MA
Recommend
CEO approval
Business outlook
Pros
Excellent company growth in the last five years. Pay equity. Engaging mission, science and motivated employees. Outstanding talents with rich expertise across R&D.
Cons
Bureaucracy slow down decision making. Conservative leadership in some disease areas impeding innovation due to risk avoidance. Wavering in decision making due to bias, presumptions or premature data.